10 of the biggest lies Donald Trump told about Trumpcare.

During his campaign for president, Donald Trump set himself apart from the other Republicans vying for the nomination by claiming his election would mean a new health care system — one with lower costs, better care, and universal coverage. It all sounded pretty good, actually.

But now that he's in office, his tune has changed.


Trump has endorsed both the House and Senate versions of health care reform, even though they're exactly the types of plans he claimed he was against: ones that gut Medicaid, reduce the number of people with health insurance, and do nothing to control costs.

On Monday, the nonpartisan Congressional Budget Office confirmed the Senate's bill is as bad as originally thought, leaving 22 million additional people uninsured.

So what gives? Was Trump lying during the campaign (something he has more than a bit of history with), or does he simply not know what he's endorsing? Whatever these new health care bills are, they're not what he promised.

Here are 10 of the biggest differences between what Trump promised and what he helped deliver.

1. Everybody will have health insurance and access to care.

"We’re going to have insurance for everybody. There was a philosophy in some circles that if you can’t pay for it, you don’t get it. That’s not going to happen with us." —Trump in a Jan. 15, 2017, Washington Post interview

GIF from CBS/YouTube.

GIF from CBS/YouTube.

While Trump has claimed to support making sure everybody has access to health care numerous times over the past two decades (In 2015, he even proposed a government-funded system on "60 Minutes"), this bill will cause 22 million more people to lose access to care.

2. Health insurance will cover more, cost less, and have lower deductibles.

"We will create quality, reliable, affordable health care in a free market where parents can make the health care decisions that they really want to make for their families. It will be a much better health care at a much less expensive cost." — Trump at a Nov. 1, 2016, rally in Valley Forge, Pennsylvania

"Care will get better and costs will go down" is a great bumper-sticker-ready slogan, but it's not realistic.

The ACA slowed the pace of annual premium increases to the lowest they've been in decades. The truth is that both House and Senate versions of the new health care bill will lead to skyrocketing premiums and won't do much in terms of lowering deductibles either. As far as the "great health care" aspect of this goes, eliminating essential health benefits will lower the overall quality of health insurance plans.

3. People with pre-existing conditions won't lose coverage.

GIF from Face the Nation/YouTube.

While both House and Senate bills say insurance companies can't deny someone coverage on the basis of pre-existing conditions, insurance companies will once again be allowed to charge those people a significantly higher premium, pricing them out of the market, which will have the same effect.

4. There will be no cuts to Medicaid.

GIF from Daily Signal/YouTube.

The Senate's bill guts the program. Full stop. If passed, it'd be the largest cut in the program's history.

5. Health care reform would "fix our broken mental health system."

"We must expand treatment programs, and reform the laws to make it easier to take preventive action to save innocent lives. Most people with mental health problems are not violent, but just need help, and these reforms will help everyone." — Trump's campaign website

The proposed cuts to Medicaid and allowing states to opt out of essential health benefits (such as coverage for mental health services) will actively make things worse.

6. Under the new bill, Trump promised that "you will be able to choose your own doctor."

"We will repeal and replace disastrous Obamacare. You will be able to choose your own doctor again." — Trump's July 21, 2016, acceptance speech at the Republican National Convention in Cleveland, Ohio

GIF from White House/YouTube.

This promise seems mostly to be a jab at President Barack Obama's claim that the Affordable Care Act would let people keep their existing doctor and insurance plans if they wanted to — something the legislation couldn't back up. It's been one of Trump's go-to lines over the years, tweeting about it 18 times and counting.

But there's one major problem with Trump's promise to restore the ability to "choose your own doctor again": It doesn't actually address this issue. Losing your insurance due to premium increases or an employer's decision to go with a different carrier is an issue that long pre-dates the ACA, as is the fact that the insurance accepted by doctors can also change at a moment's notice. The ACA didn't fix that, and neither do the House or Senate reform bills.

7. "Require price transparency from all health care providers."

"Require price transparency from all healthcare providers, especially doctors and healthcare organizations like clinics and hospitals. Individuals should be able to shop to find the best prices for procedures, exams or any other medical-related procedure." — Trump's campaign website

One thing that the ACA didn't do nearly enough is work to control health provider costs. And neither the House or Senate health care proposals do either. This isn't addressed.

8. It will be legal to purchase prescription drugs from other countries.

"Remove barriers to entry into free markets for drug providers that offer safe, reliable and cheaper products. ... Allowing consumers access to imported, safe and dependable drugs from overseas will bring more options to consumers. The reforms outlined above will lower healthcare costs for all Americans." — Trump's campaign website

On the surface, being able to reimport drugs from Canada and other countries sounds like a pretty great cost-cutting measure for consumers. There's definitely a debate over whether this would actually lower costs, but the truth is that this isn't addressed in either the House or Senate health care bills.

9. "People aren't going to be dying on the sidewalks and in the street."

"The people aren't going to be dying on the sidewalks and in the street, not if I'm president. So we'll work out a deal. We'll get them into the hospital. We'll get them in to see doctors. ... But I'm not going to allow people to die on the sidewalks in the street." — Feb. 29, 2016, episode of "Hannity"

Location aside and with 22 million more people standing to lose health care, people will die under this bill. Making it harder to pay for health care means it will be harder for people to actually get that much needed medicine, health exam, or admittance into a hospital or treatment program that could save their life.

10. "This is a repeal and replacement of Obamacare."

Both the House and Senate bills amend portions of the ACA, but they don't actually repeal the law.

Hillary Clinton ran on amending the ACA to address a number of specific issues related to the rising cost of care, the opioid crisis, premium increases, a lack of consumer choice, and more. During the campaign, Trump spoke mainly in vague platitudes about what he'd like his health care plan to be ("great," "wonderful," and so on) with very sparse specifics. One of those specifics, however, was to repeal and replace Obamacare.

This bill doesn't do that. Instead, it chips away at an existing system without offering solutions for the overwhelming majority of the country.

Photo by Mark Wilson/Getty Images.

It's not too late to do something about it.

No matter who you voted for, no matter what your political views are, this bill isn't what voters signed up for. The Senate hopes to bring the bill up for a vote sometime this week. The best thing you can do between now and then is to give your senators a call and let them know that you want them to vote no.

The past three presidential administrations have been a game of ping-pong for LBGTQ+ students' rights. During his term as president, Trump rescinded Obama-era protections for transgender students, and now the Biden administration is undoing that Trump-era guidance.

An announcement from the U.S. Department of Education today clarified that transgender and gay students are protected from discrimination under Title IX.

"Today, the Department makes clear that all students — including LGBTQ+ students —deserve the opportunity to learn and thrive in schools that are free from discrimination," Secretary of Education Miguel Cardona said in a statement.

"The Supreme Court has upheld the right for LGBTQ+ people to live and work without fear of harassment, exclusion, and discrimination – and our LGBTQ+ students have the same rights and deserve the same protections."

Keep Reading Show less

The past three presidential administrations have been a game of ping-pong for LBGTQ+ students' rights. During his term as president, Trump rescinded Obama-era protections for transgender students, and now the Biden administration is undoing that Trump-era guidance.

An announcement from the U.S. Department of Education today clarified that transgender and gay students are protected from discrimination under Title IX.

"Today, the Department makes clear that all students — including LGBTQ+ students —deserve the opportunity to learn and thrive in schools that are free from discrimination," Secretary of Education Miguel Cardona said in a statement.

"The Supreme Court has upheld the right for LGBTQ+ people to live and work without fear of harassment, exclusion, and discrimination – and our LGBTQ+ students have the same rights and deserve the same protections."

Keep Reading Show less
True

Each year, an estimated 1.8 million people in the United States are affected by cancer — most commonly cancers of the breast, lung, prostate, and blood cancers such as leukemia. While not everyone overcomes the disease, thanks to science, more people are surviving — and for longer — than ever before in history.

We asked three people whose lives have been impacted by cancer to share their stories – how their lives were changed by the disease, and how they're using that experience to change the future of cancer treatments with the hope that ultimately, in the fight against cancer, science will win. Here's what they had to say.

Celine Ryan, 55, engineer database programmer and mother of five from Detroit, MI

Photo courtesy of Celine Ryan

In September 2013, Celine Ryan woke up from a colonoscopy to some traumatic news. Her gastroenterologist showed her a picture of the cancerous mass they found during the procedure.

Ryan and her husband, Patrick, had scheduled a colonoscopy after discovering some unusual bleeding, so the suspicion she could have cancer was already there. Neither of them, however, were quite prepared for the results to be positive -- or for the treatment to begin so soon. Just two days after learning the news, Ryan had surgery to remove the tumor, part of her bladder, and 17 cancerous lymph nodes. Chemotherapy and radiation soon followed.

Ryan's treatment was rigorous – but in December 2014, she got the devastating news that the cancer, once confined to her colon, had spread to her lungs. Her prognosis, they said, was likely terminal.

But rather than give up hope, Ryan sought support from online research, fellow cancer patients and survivors, and her medical team. When she brought up immunotherapy to her oncologist, he quickly agreed it was the best course of action. Ryan's cancer, like a majority of colon and pancreatic cancers, had been caused by a defect on the gene KRAS, which can result in a very aggressive cancer that is virtually "undruggable." According to the medical literature, the relatively smooth protein structure of the KRAS gene meant that designing inhibitors to bind to surface grooves and treat the cancer has been historically difficult. Through her support systems, Ryan discovered an experimental immunotherapy trial at the National Institutes of Health (NIH) in Bethesda, MD., and called them immediately to see if she was eligible. After months of trying to determine whether she was a suitable candidate for the experimental treatment, Ryan was finally accepted.

The treatment, known as tumor-infiltrating lymphocyte therapy, or TIL, is a testament to how far modern science has evolved. With this therapy, doctors remove a tumor and harvest special immune cells that are found naturally in the tumor. Doctors then grow the cells in a lab over the next several weeks with a protein that promotes rapid TIL growth – and once the cells number into the billions, they are infused back into the patient's body to fight the cancer. On April 1, 2015, Ryan had her tumor removed at the NIH. Two months later, she went inpatient for four weeks to have the team "wash out" her immune system with chemotherapy and infuse the cells – all 148 billion of them – back into her body.

Six weeks after the infusion, Ryan and Patrick went back for a follow-up appointment – and the news they got was stunning: Not only had no new tumors developed, but the six existing tumors in her lungs had shrunk significantly. Less than a year after her cell infusion, in April 2016, the doctors told Ryan news that would have been impossible just a decade earlier: Thanks to the cell infusion, Ryan was now considered NED – no evaluable disease. Her body was cancer-free.

Ryan is still NED today and continuing annual follow-up appointments at the NIH, experiencing things she never dreamed she'd be able to live to see, such as her children's high school and college graduations. She's also donating her blood and cells to the NIH to help them research other potential cancer treatments. "It was an honor to do so," Ryan said of her experience. "I'm just thrilled, and I hope my experience can help a lot more people."

Patrice Lee, PhD, VP of Pharmacology, Toxicology and Exploratory Development at Pfizer

Photo courtesy of Patrice Lee

Patrice Lee got into scientific research in an unconventional way – through the late ocean explorer Jacques Cousteau.

Lee never met Cousteau but her dreams of working with him one day led her to pursue a career in science. Initially, Lee completed an undergraduate degree in marine biology; eventually, her interests changed and she decided to get a dual doctoral degree in physiology and toxicology at Duke University. She now works at Pfizer's R&D site in Boulder, CO (formerly Array BioPharma), leading a group of scientists who determine the safety and efficacy of new oncology drugs.

"Scientists focused on drug discovery and development in the pharmaceutical industry are deeply committed to inventing new therapies to meet unmet needs," Lee says, describing her field of work. "We're driven to achieve new medicines and vaccines as quickly as possible without sacrificing safety."

Among the drugs Lee has helped develop during her career, including cancer therapies, she says around a dozen are currently in development, while nine have received FDA approval — an incredible accomplishment as many scientists spend their careers without seeing their drug make it to market. Lee's team is particularly interested in therapies for brain metastases — something that Lee says is a largely unmet need in cancer research, and something her team is working on from a variety of angles. "Now that we've had rapid success with mRNA vaccine technology, we hope to explore what the future holds when applying this technology to cancers," Lee says.

But while evaluating potential cancer therapies is a professional passion of Lee's, it's also a mission that's deeply personal. "I'm also a breast cancer survivor," she says. "So I've been on the other side of things and have participated in a clinical trial."

However, seeing how melanoma therapies that she helped develop have affected other real-life cancer patients, she says, has been a highlight of her career. "We had one therapy that was approved for patients with BRAF-mutant metastatic melanoma," Lee recalls. "Our team in Boulder was graced by a visit from a patient that had benefited from these drugs that we developed. It was a very special moment for the entire team."

None of these therapies would be available, Lee says without rigorous science behind it: "Facts come from good science. Facts will drive the development of new drugs, and that's what will help patients."

Chiuying "Cynthia" Kuk (they/them) MS, 34, third-year medical student at Michigan State University College of Human Medicine

Photo courtesy of Cynthia Kuk

Cynthia Kuk was just 10 years old when they had a conversation that would change their life forever.

"My mother, who worked as a translator for the government at the time, had been diagnosed with breast cancer, and after her chemotherapy treatments she would get really sick," Kuk, who uses they/them pronouns, recalls. "When I asked my dad why mom was puking so much, he said it was because of the medicine she was taking that would help her get better."

Kuk's response was immediate: "That's so stupid! Why would a medicine make you feel worse instead of better? When I'm older, I want to create medicine that won't make people sick like that."

Nine years later, Kuk traveled from their native Hong Kong to the United States to do exactly that. Kuk enrolled in a small, liberal arts college for their Bachelor's degree, and then four years later started a PhD program in cancer research. Although Kuk's mother was in remission from her cancer at the time, Kuk's goal was the same as it had been as a 10-year-old watching her suffer through chemotherapy: to design a better cancer treatment, and change the landscape of cancer research forever.

Since then, Kuk's mission has changed slightly.

"My mom's cancer relapsed in 2008, and she ended up passing away about five years after that," Kuk says. "After my mom died, I started having this sense of urgency. Cancer research is such that you work for twenty years, and at the end of it you might have a fancy medication that could help people, but I wanted to help people now." With their mother still at the forefront of their mind, Kuk decided to quit their PhD program and enter medical school.

Now, Kuk plans to pursue a career in emergency medicine – not only because they are drawn to the excitement of the emergency room, but because the ER is a place where the most marginalized people tend to seek care.

"I have a special interest in the LGBTQ+ population, as I identify as queer and nonbinary," says Kuk. "A lot of people in this community and other marginalized communities access care through the ER and also tend to avoid medical care since there is a history of mistreatment and judgement from healthcare workers. How you carry yourself as a doctor, your compassion, that can make a huge difference in someone's care."

In addition to making a difference in the lives of LGBTQ+ patients, Kuk wants to make a difference in the lives of patients with cancer as well, like their mother had.

"We've diagnosed patients in the Emergency Department with cancer before," Kuk says. "I can't make cancer good news but how you deliver bad news and the compassion you show could make a world of difference to that patient and their family."

During their training, Kuk advocates for patients by delivering compassionate and inclusive care, whether they happen to have cancer or not. In addition to emphasizing their patient's pronouns and chosen names, they ask for inclusive social and sexual histories as well as using gender neutral language. In doing this, they hope to make medicine as a whole more accessible for people who have been historically pushed aside.

"I'm just one person, and I can't force everyone to respect you, if you're marginalized," Kuk says. "But I do want to push for a culture where people appreciate others who are different from them."